For the 2nd year running, UTCBS is hosting a delegation of South African researchers as part of a bilateral PHC

Oct 30, 2024 | Laboratory UTCBS

For the 2nd year running, UTCBS is hosting a delegation of South African researchers as part of a bilateral PHC Pretoria project obtained by Prof. Yohann Corvis between UTCBS and the “Pharmaceutical Sciences Laboratory” at Sefako Makgatho Health Sciences University in...

CNRS honors Néovacs and UTCBS, united for a therapeutic RNA vaccine against asthma

Aug 30, 2024 | Laboratory UTCBS, Research

Suresnes, August 29, 2024 – 8am CET – Neovacs (Euronext Growth Paris : ALNEV), a preclinical-stage biopharmaceutical company developing novel therapies for inflammatory and autoimmune diseases, is honored to be listed among the latest CNRS publications...

Publication in Advanced Science of Preclinical tests obtained with a pFAR plasmid

Aug 22, 2024 | Laboratory UTCBS, Research

Gene Electrotransfer via Conductivity-Clamped Electric Field Focusing Pivots Sensori-Motor DNA Therapeutics: “A Spoonful of Sugar Helps the Medicine Go Down” https://doi.org/10.1002/advs.202401392

Khair Alareth, Caroline Roques and Nasir Arafath with Nathalie Mignet to present UTCBS’s work at the Controlled release society international congress in Bologna.

Jul 11, 2024 | Laboratory UTCBS, Symposium

UTCBS presents its work at the international congress of the “controlled release society” in Bologna. The UTCBS team has shown the interest of nanoparticles  both for the imaging of ROS in vivo and the promotion of antioxydant therapeutic activity....

The Alnylam Pharmaceuticals 2024 “Interfering RNA & Rare Diseases” Prize has been awarded to Virginie Escriou,

Jun 20, 2024 | Laboratory UTCBS

The Alnylam Pharmaceuticals 2024 “Interfering RNA & Rare Diseases” Prize has been awarded to Virginie Escriou, for her research entitled “Therapeutic strategies based on orally administered siRNA”. The prize was delivered at the Annual...